Exagen, Inc. (XGN)
8.17
+0.28
(+3.55%)
USD |
NASDAQ |
Oct 02, 16:00
8.14
-0.03
(-0.37%)
After-Hours: 20:00
Exagen Gross Profit Margin (Quarterly) : 61.27% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 61.27% |
| March 31, 2026 | 58.97% |
| December 31, 2025 | 55.35% |
| September 30, 2025 | 58.43% |
| June 30, 2025 | 60.43% |
| March 31, 2025 | 58.87% |
| December 31, 2024 | 62.08% |
| September 30, 2024 | 55.82% |
| June 30, 2024 | 60.12% |
| March 31, 2024 | 59.65% |
| December 31, 2023 | 59.17% |
| September 30, 2023 | 57.44% |
| June 30, 2023 | 58.72% |
| March 31, 2023 | 47.23% |
| December 31, 2022 | 50.85% |
| September 30, 2022 | 59.19% |
| June 30, 2022 | 20.09% |
| March 31, 2022 | 44.04% |
| December 31, 2021 | 61.08% |
| September 30, 2021 | 55.21% |
| June 30, 2021 | 57.32% |
| March 31, 2021 | 55.50% |
| December 31, 2020 | 65.78% |
| Date | Value |
|---|---|
| September 30, 2020 | 59.71% |
| June 30, 2020 | 62.70% |
| March 31, 2020 | 52.58% |
| December 31, 2019 | 55.05% |
| September 30, 2019 | 54.18% |
| June 30, 2019 | 52.34% |
| March 31, 2019 | 52.03% |
| December 31, 2018 | 58.48% |
| September 30, 2018 | 52.58% |
| June 30, 2018 | 49.65% |
| March 31, 2018 | 45.55% |
| December 31, 2015 | 42.62% |
| September 30, 2015 | 45.41% |
| June 30, 2015 | 44.60% |
| March 31, 2015 | 50.37% |
| December 31, 2014 | 47.55% |
| September 30, 2014 | 43.98% |
| June 30, 2014 | 32.84% |
| March 31, 2014 | 11.03% |
| December 31, 2013 | 14.55% |
| September 30, 2013 | 14.55% |
| June 30, 2013 | -11.45% |
| March 31, 2013 | -57.30% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Myriad Genetics, Inc. | 62.51% |
| BioRestorative Therapies, Inc. | -157.8% |
| CareDx, Inc. | 73.37% |
| Natera, Inc. | 63.70% |
| Sera Prognostics, Inc. | -606.7% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -113.6% |
| Return on Assets | -33.24% |
| Return on Invested Capital | -43.18% |
| Profit Margin (Quarterly) | -16.03% |
| Operating Margin (Quarterly) | -8.64% |
| Return on Net Operating Assets | -70.08% |